학술논문

1310P VinMetAtezo: Phase II trial of metronomic oral vinorelbine (MOV) with atezolizumab (ATZ) for recurrent stage IV NSCLC (GFPC*04-18)**
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S847-S847
Subject
Language
ISSN
0923-7534